The discovery-to-market journey is now more complex and expensive than ever before
Learn to Leverage the Modern Lab:
Quantify the tools used within the lab while incorporating built-in flexibility in order to maximize your resources
Anticipate the benefits of the pre-competitive space in pulling resources together to save time and lower costs
Enable your technicians & scientists to further advance through increased data visibility
Best practices for externalization of your CRO's and creating one standard stream of communication
Global harmonization of your different sites in order to create a standardized system of sharing data
Manage and properly utilize the volume & velocity of data collected through automation
Executive Director Business Development North America
Director Data Architecture Translational Informatics
Janssen, Pharmaceutical Companies of Johnson and Johnson
Senior Vice President & CIO, Innovation Architects
Director, MRL IT
Mgr I, IT
Associate Director, Emerging Science & Innovation
Johnson & Johnson
Associate Director, R&D IT
Assistant Dean for Informatics
Manager, Technical Operations IT
Director, Research Analytics
Senior Director, MRL IT
Senior Scientist, HTE and Lead Discovery Capabilities
Merck Research Laboratories
Senior Director, Information and Research Technologies
The Jackson Laboratory
Principle System Analyst
The Broad Institute
Johnson & Johnson
Associate Principal Scientist, Cheminformatics
New Focus Areas
Integrate your fragmented infrastructure to allow for innovation and discovery
Increase your predictive analytical capabilities to decrease cost and time of clinical trials
Streamline tech-transfers and processes to reduce bottlenecks and delays
Create a transparent data architecture to harmonize validation and regulatory submissions
What Others Have to Say
"High level overview of the topics raised in the agenda. Very good networking event; leaders represent the companies. Enjoyed the possibility that we could talk to anybody-opportunity for in-depth discussions."
"Very informative event with focus on relevant subjects and current challenges for Laboratory Informatics on Pharmaceutical/Biotech industries."
"Understanding of initiatives across companies and meeting people from large/small biotech/pharmaceuticals."
"I was pleasantly surprised by the diversity. Bringing consistently high quality speakers with diverse points of view is a winning strategy."
"Fantastic feedback from folks on ELN/UMS systems."
Laboratory Informatics Market - Forecasts to 2021
This is a sample report courtesy of ASD Reports, The global laboratory informatics market is projected to grow during the forecast period of 2016 to 2021. The market for laboratory informatics solutions is expanding with the increasing need for laboratory automation, technological advancements, increasing availability of cost-effective informatics solutions, rising pressure to comply with regulatory requirements, and increasing adoption of laboratory informatics in biobanks/biorepositories, academic research institutes, and contract service organizations.
3 Strategies For Implementing an End-to-End Evaluation of Your Lab Informatics Database
Elizabeth Admirand, Principal Research Associate in Lead Discovery at Epizyme, outlines strategies in how they’ve been implementing an end-to-end evaluation of their lab informatics database, and what the major benefits of completing an end-to-end evaluation of their lab info systems have been. And discusses much more!